Results
Hester Biosciences Q2 PAT Surges 131% YoY
• Hester Biosciences reported standalone Q2 FY27 PAT growth of 131% YoY and revenue growth of 28% YoY, driven by poultry healthcare performance.
• The company capitalized its BSL-3 laboratory and fill
